Enhanced bioavailability of cyclosporine using a new oral formulation (Sandimmun optoral) in a liver-grafted patient with severe cholestasis.
Winkler
M
M
Ringe
B
B
Schneider
K
K
Maibücher
A
A
Färber
L
L
Wietholtz
H
H
Manns
M
M
Pichlmayr
R
R
D000284:Administration, Oral; D001682:Biological Availability; D002779:Cholestasis / Q000150:complications* / Q000378:metabolism; D016572:Cyclosporine / Q000493:pharmacokinetics*; D004655:Emulsions; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007408:Intestinal Absorption; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged
D004655:Emulsions; D016572:Cyclosporine